Advancing Atherosclerotic Cardiovascular Disease Trials Through Innovative Imaging Endpoints

July 2025

Publication: Prof Charalambos Antoniades, University of Oxford, Dr Rina Ariga, Medical Director, Cardiology, Medpace, Dr Andrea Flannery, Clinical Trial Management Director, Medpace

Source / Author: Medpace Webinar

The detection of coronary inflammation is emerging as a powerful means of advancing research in atherosclerotic cardiovascular disease (ASCVD).

In this webinar, experts from Medpace and Caristo Diagnostics explore the growing role of imaging endpoints in ASCVD trials, with a focus on the fat attenuation index (FAI) score, a groundbreaking imaging biomarker of coronary inflammation.

Watch this webinar to:

  • Learn how the integration of FAI-based endpoints is set to transform clinical trials in ASCVD.
  • Gain an understanding of the scientific basis behind FAI and its validation in large-scale studies.
  • Understand how this technology enables early disease detection, patient risk stratification and more responsive endpoints. The panel will offer practical guidance into incorporating imaging endpoints into the next generation of ASCVD trials.

Learn more about this webinar on Medpace.

###